X About
Xaira Therapeutics is building a generative AI platform focused on de novo protein design and drug candidate creation, leveraging advancements from the technology behind AlphaFold. The company’s core innovation lies in applying AI to not just predict protein structures, but to generate novel protein therapeutics with optimized properties for a range of diseases. Backed by a $1 billion Series A funding round, Xaira Therapeutics aims to accelerate drug discovery beyond traditional methods and is initially focusing on developing therapeutics for currently undruggable targets.
Focus Areas
Technology Focus
drug discovery healthcare ai generative ai
Key People 3
- Marc Tessier-Lavigne
- David Baker
- Hetu Kamisetty
Quick Stats
- Total Raised
- $1.0B
- Founded
- 2024
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
Tempus AI
Chicago, United States
95%
2 shared categories
3 shared AI types
Same country
Healthcare AIDrug Discovery
Genesis Therapeutics
Burlingame, United States
85%
2 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI
Verge Genomics
San Francisco, United States
85%
2 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI
BPGbio
Framingham, United States
85%
2 shared categories
2 shared AI types
Same country
Drug DiscoveryHealthcare AI